𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Strategies for cancer gene therapy

✍ Scribed by Rhiannon M. Hughes


Publisher
John Wiley and Sons
Year
2003
Tongue
English
Weight
90 KB
Volume
85
Category
Article
ISSN
0022-4790

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Gene therapy for cancer
✍ Bert O'Malley πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 34 KB
Gene therapy for pancreatic cancer
✍ Shin Takeda; Akimasa Nakao; Koji Miyoshi; Hiroshi Takagi πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 36 KB πŸ‘ 2 views

It has been approximately 7 years since the introduction of gene therapy. Since conventional procedures such as surgery, chemotherapy, and radiotherapy have had limited therapeutic value for cancer patients, the evolution of gene therapy seems a promising alternative to many researchers and clinicia

Gene therapy for lung cancer
✍ Eric M. Toloza; Michael A. Morse; H. Kim Lyerly πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 218 KB

## Abstract Lung cancer patients suffer a 15% overall survival despite advances in chemotherapy, radiation therapy, and surgery. This unacceptably low survival rate is due to the usual finding of advanced disease at diagnosis. However, multimodality strategies using conventional therapies only mini

Gene therapy strategies for hemophilia:
✍ Inge Petrus; Marinee Chuah; Thierry VandenDriessche πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 167 KB

## Abstract Hemophilia is an inherited bleeding disorder caused by a deficiency of functional clotting factors VIII or IX in the blood plasma. The drawbacks of the classical protein substitution therapy fueled interest in alternative treatments by gene therapy. Hemophilia has been recognized as an

Modified adenoviruses for cancer gene th
✍ Anna Kanerva; Akseli Hemminki πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 French βš– 152 KB

## Abstract Adenoviral gene therapy is an exciting novel approach for treating cancers resistant to currently available therapies. However, currently there is little evidence supporting significant clinical benefits with replication‐incompetent adenoviruses. Recent data suggest that expression of t